Impact of the Inflation Reduction Act on US health care: an interview with Corey Ford and Kimberly Westrich, Xcenda

In August 2022, the Inflation Reduction Act (IRA) was signed into law in the United States with the aim of transforming health care by curbing spending and lowering drug costs. A landmark piece of legislation, the law includes a number of provisions aimed at lowering prescription drug prices, expanding access to health insurance, and improving the quality of care. In this interview, we speak with Corey Ford and Kimberly Westrich of AmerisourceBergen’s Xcenda to explore the law's provisions and its wider implications for drug development, health care and health policy. About the interviewees Corey Ford, MHA, is a Vice President...